Robert F. Kennedy Jr.

Person

Last mentioned: Mar 24, 2026

Timeline

  1. Federal Injunction

    A federal judge issues a temporary block on the administration's vaccine agenda, citing public health risks.

  2. Court Ruling

    Judge Brian Murphy issues a stay, halting the implementation of the vaccine overhaul.

  3. Legal Challenge

    The AAP and ACP file suit in Massachusetts federal court to block the changes.

  4. Proposed Schedule Changes

    The administration proposes sweeping changes to the national pediatric immunization schedule.

  5. Policy Shift Initiated

    RFK Jr. begins implementing a new agenda for federal vaccine oversight and safety reviews.

  6. ACIP Restructuring

    HHS replaces existing ACIP members with figures aligned with the administration's views.

  7. HHS Policy Shift

    Secretary RFK Jr. issues a memo reducing universal vaccine recommendations.

Stories mentioning Robert F. Kennedy Jr. 3

pharma Neutral

Federal Judge Temporarily Blocks RFK Jr.’s Vaccine Policy Overhaul

A federal judge has issued a temporary injunction against Robert F. Kennedy Jr.’s proposed changes to national vaccine policy, citing potential risks to public health. The ruling provides a reprieve for pharmaceutical manufacturers and public health agencies while the legal merits of the administration's agenda are debated.

6 sources
pharma Neutral

Federal Judge Halts RFK Jr.’s Sweeping Vaccine Policy Overhaul

A Massachusetts federal judge has blocked the Trump administration's attempts to dismantle the standard U.S. vaccine schedule. The ruling halts Robert F. Kennedy Jr.’s efforts to reduce recommended pediatric immunizations, citing a failure to follow established scientific and procedural laws.

2 sources
pharma Neutral

Scientific Studies Rebut RFK Jr. Claims on Vaccines, Tylenol, and SSRIs

Recent large-scale clinical studies are directly contradicting public health claims made by Robert F. Kennedy Jr. regarding the safety profiles of vaccines, acetaminophen, and antidepressants. These findings provide a critical scientific defense for pharmaceutical manufacturers facing increased regulatory scrutiny and litigation risks.

2 sources

About Robert F. Kennedy Jr. coverage

This page surfaces every story mentioning Robert F. Kennedy Jr. across our biotech coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running biotech beat. Cross-entity comparisons live on our compare view.

What you seeWhat it tells you
Story countNumber of distinct stories where Robert F. Kennedy Jr. was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.